ES463267A1 - Un procedimiento para preparar un compuesto de espiro-hidan-toina. - Google Patents

Un procedimiento para preparar un compuesto de espiro-hidan-toina.

Info

Publication number
ES463267A1
ES463267A1 ES463267A ES463267A ES463267A1 ES 463267 A1 ES463267 A1 ES 463267A1 ES 463267 A ES463267 A ES 463267A ES 463267 A ES463267 A ES 463267A ES 463267 A1 ES463267 A1 ES 463267A1
Authority
ES
Spain
Prior art keywords
therapeutic agents
hydantoin derivatives
compounds
compounds obtained
spiro hydantoin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES463267A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/767,803 external-priority patent/US4117230A/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES463267A1 publication Critical patent/ES463267A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES463267A 1976-10-18 1977-10-15 Un procedimiento para preparar un compuesto de espiro-hidan-toina. Expired ES463267A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73306276A 1976-10-18 1976-10-18
US05/767,803 US4117230A (en) 1976-10-18 1977-02-11 Hydantoin derivatives as therapeutic agents

Publications (1)

Publication Number Publication Date
ES463267A1 true ES463267A1 (es) 1978-07-16

Family

ID=27112515

Family Applications (1)

Application Number Title Priority Date Filing Date
ES463267A Expired ES463267A1 (es) 1976-10-18 1977-10-15 Un procedimiento para preparar un compuesto de espiro-hidan-toina.

Country Status (29)

Country Link
JP (3) JPS5353653A (nl)
AR (1) AR220901A1 (nl)
AT (1) AT356136B (nl)
AU (1) AU504978B2 (nl)
BG (1) BG28847A3 (nl)
CA (1) CA1088945A (nl)
CH (1) CH625511A5 (nl)
DD (1) DD131931A5 (nl)
DE (4) DE2759543C2 (nl)
DK (1) DK150302C (nl)
ES (1) ES463267A1 (nl)
FI (1) FI62307C (nl)
FR (1) FR2367754A1 (nl)
GB (1) GB1566171A (nl)
GR (1) GR70201B (nl)
HK (1) HK53881A (nl)
IE (1) IE45805B1 (nl)
IL (1) IL53094A0 (nl)
KE (1) KE3167A (nl)
LU (1) LU78330A1 (nl)
MX (1) MX4899E (nl)
MY (1) MY8200157A (nl)
NL (1) NL167434C (nl)
NO (1) NO148453C (nl)
NZ (1) NZ185358A (nl)
PH (1) PH15639A (nl)
PT (1) PT67164B (nl)
SE (1) SE437024B (nl)
YU (1) YU40821B (nl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4127665A (en) * 1978-01-18 1978-11-28 Pfizer Inc. Thienohydantoin derivatives
US4147797A (en) * 1978-08-11 1979-04-03 Pfizer Inc. Spiro-furanohydantoin derivatives
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4181728A (en) * 1978-11-16 1980-01-01 Pfizer Inc. Spiro-polycyclicimidazolidinedione derivatives
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives
US4283409A (en) * 1979-10-29 1981-08-11 Pfizer Inc. Imidazolone derivatives
US4286098A (en) * 1980-03-28 1981-08-25 Pfizer Inc. Process for the preparation of chiral hydantoins
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
ATE11781T1 (de) * 1981-05-13 1985-02-15 Imperial Chemical Industries Plc Pharmazeutische zubereitungen, die spirosuccinimidderivate enthalten.
JPS58213717A (ja) * 1982-01-20 1983-12-12 Eisai Co Ltd ヒダントイン誘導体を含有する治療用薬剤
JPS59500617A (ja) * 1982-04-15 1984-04-12 アルコン・ラボラトリ−ズ・インコ−ポレ−テッド ヒダントイン治療剤
ZA839023B (en) * 1982-12-06 1985-07-31 Pfizer Spiro-3-hetero-azolones for treatment of diabetic complications
US4474967A (en) * 1983-04-27 1984-10-02 Pfizer Inc. 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
HU198051B (en) * 1984-10-30 1989-07-28 Pfizer Process for producing spiro square brackets open imidazolidine-4,5'(6h)-quinoline square brackets closed-2,5-dione derivatives
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
US4575507A (en) * 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
JPS6357588A (ja) * 1986-08-28 1988-03-12 Sanwa Kagaku Kenkyusho Co Ltd ヒダントイン誘導体、その塩並びに該化合物を有効成分とする糖尿病合併症の予防及び治療剤
MX12896A (es) * 1987-09-04 1993-06-01 Pfizer Procedimiento para preparar un compuesto de espiro-heteroazolonas
GB2355264A (en) 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists
WO2003088915A2 (en) 2002-04-18 2003-10-30 University Of Virginia Patent Foundation Novel sodium channel blockers
FR2955107B1 (fr) 2010-01-08 2012-03-02 Servier Lab Nouveaux derives thiochromanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB818724A (en) * 1956-10-18 1959-08-19 Ici Ltd Hydantoin derivatives
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
DE2449030A1 (de) * 1974-10-11 1976-05-20 Schering Ag Neue pyridin-derivate
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents

Also Published As

Publication number Publication date
CA1088945A (en) 1980-11-04
YU40821B (en) 1986-06-30
FI62307B (fi) 1982-08-31
AU504978B2 (en) 1979-11-01
FR2367754B1 (nl) 1982-07-09
PT67164B (en) 1979-03-20
FR2367754A1 (fr) 1978-05-12
IE45805B1 (en) 1982-12-01
FI62307C (fi) 1982-12-10
YU244277A (en) 1982-08-31
DE2759543C2 (de) 1987-04-09
AT356136B (de) 1980-04-10
AU2943177A (en) 1979-04-12
DE2746244C2 (de) 1983-05-19
PH15639A (en) 1983-03-11
JPS607997B2 (ja) 1985-02-28
DE2759927C2 (de) 1986-12-04
NZ185358A (en) 1979-06-08
JPS5495570A (en) 1979-07-28
AR220901A1 (es) 1980-12-15
NL167434C (nl) 1981-12-16
BG28847A3 (en) 1980-07-15
SE7711053L (sv) 1978-04-19
GR70201B (nl) 1982-08-31
LU78330A1 (fr) 1979-06-01
KE3167A (en) 1981-11-06
DE2746244A1 (de) 1978-04-20
NL7711358A (nl) 1978-04-20
ATA745977A (de) 1979-09-15
NL167434B (nl) 1981-07-16
HK53881A (en) 1981-11-13
DK461377A (da) 1978-04-19
NO148453B (no) 1983-07-04
JPS5495575A (en) 1979-07-28
SE437024B (sv) 1985-02-04
FI773060A (fi) 1978-04-19
IL53094A0 (en) 1977-12-30
IE45805L (en) 1978-04-18
DK150302B (da) 1987-02-02
DD131931A5 (de) 1978-08-09
MX4899E (es) 1982-12-14
MY8200157A (en) 1982-12-31
DK150302C (da) 1987-09-28
GB1566171A (en) 1980-04-30
JPS5534132B2 (nl) 1980-09-04
CH625511A5 (en) 1981-09-30
JPS5353653A (en) 1978-05-16
NO148453C (no) 1983-10-12
DE2759542C2 (nl) 1988-07-07
JPS5940388B2 (ja) 1984-09-29
PT67164A (en) 1977-11-01
NO773548L (no) 1978-04-19

Similar Documents

Publication Publication Date Title
ES463267A1 (es) Un procedimiento para preparar un compuesto de espiro-hidan-toina.
GB1250538A (nl)
GB1525351A (en) Benzazepine derivatives and their acid addition salts processes for preparing them and pharmaceutical compositions containing them
IE40195B1 (en) New - lactam antibiotic compounds, their production and their medicinal use
JPS5347515A (en) Gamma-globulin pharmaceutical preparation for intravenous injection
IE44047L (en) Cyanoacetanilide derivatives.
GB1394791A (en) Diphenylalkyllactamimide derivatives
JPS5233682A (en) Preparation of 1,3-bis(2'-tetrahydrofuryl)-5-flurouracil
ES446187A1 (es) Un metodo de preparar nuevos compuestos de oxima-eter.
GB1324676A (en) Derivatives of 1,7,7-trimethyl-2-norbornane-2-spiro-1,3-dioxolane their process of preparation and their therapeutic application
JPS51115402A (en) Process for preparation of alpha-amino acid
FR2129914A2 (en) Sulphonic acid salts of aliphatic diamines - with antiviral activity
JPS5271448A (en) Synthesis of 2-crotonyloxymethyl-(4r,5r,6r)-4,5,6-trihydroxy-cyclohex- 2-enone
FR2216918A1 (en) Herbicidal ferrous salts of chlorobenzoic and phenoxyalkanoic acids - with low phytotoxicity to grasses
JPS51133296A (en) Processes for preparing 7-acylamino- 3-hydroxymethyl-2-cephem-4-carbox ylic acid derivatives
GB999710A (en) Hypoglycemic sulphonyl urea medicaments
ES360153A1 (es) Procedimiento para la preparacion de bencilideno-amido-hi- dracinas.
ES434751A1 (es) Un procedimiento para la obtencion de derivados del acido indanilpropionico.
GB1471371A (en) Cyclopenteno-b-pyridine derivative
DE3265652D1 (en) Novel compound having analgesic, antiinflammatory and antipyretic activity, process for its preparation and pharmaceutical compositions containing it
NL7703682A (nl) Werkwijze ter bereiding van een geneesmiddel, zo gevormd geneesmiddel en werkwijze ter berei- ding van geneeskrachtige verbindingen.
FR2159198A1 (en) 1-benzoyloxyethylpiperazines - with spasmolytic diuretic hypotensive, analgesic vasodilator and antiinflammatory activity
JPS5287159A (en) Novel antibiotics aclacinomycins a and b, and antimalignant tumor agen ts containing them as active constituent
BE803893A (en) Triamcinolone acetonide 21-valerate - as antiinflammatory agent for topical use
NL7310230A (nl) Werkwijze ter bereiding van anti-ontstekings- preparaten en aldus verkregen preparaten.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980401